AEON Biopharma Inc - The company's actions are expected to be sufficient to extend its cash flow to the fourth quarter of 2024
AEON Biopharma Inc-公司的行动预计足以将其现金流延长至2024年第四季度
AEON Biopharma Inc - The company's actions are expected to be sufficient to extend its cash flow to the fourth quarter of 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.